Cryptophycin Thioesterase Macrocyclization for Anticancer Agent Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing and using cryptophycin analogs are limited by challenges in lead optimization and costly synthetic efforts, which hinder their exploration as effective anticancer agents, particularly for difficult-to-treat cancers like colorectal cancer.
Innovation Solution
Development of novel cryptophycin chain elongation intermediates using a cryptophycin thioesterase (CrpTE) to catalyze macrocyclization, enabling the production of analogs with enhanced potency and reduced toxicity, and their conjugation with antibodies or peptides for targeted cancer therapy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If conventional synthetic methods are used to produce cryptophycin analogs, then the synthesis process is established, but the synthetic efforts are costly and lead optimization is challenging
Solution Approach 1:
The patent replaces conventional chemical synthesis methods with an enzymatic system. Specifically, it uses a thioesterase enzyme (CrpTE) to catalyze the macrocyclization reaction that forms the cryptophycin core structure. This biochemical approach substitutes the mechanical/chemical synthesis process with an enzyme-driven transformation, enabling more efficient and cost-effective production of cryptophycin analogs with improved lead optimization capabilities.
2Productivity
If the thioesterase enzyme is used for macrocyclization, then the synthesis efficiency is improved, but the enzyme's substrate specificity may limit the range of analogs that can be produced
Solution Approach 1:
The patent employs parameter changes by modifying the enzyme's active site through mutagenesis. Specific amino acid residues in the CrpTE active site were mutated to alter substrate binding characteristics and catalytic properties. This allows the enzyme to accommodate a broader range of substrate structures while maintaining high synthesis efficiency, thereby resolving the contradiction between productivity and adaptability.
Solution Approach 2:
Through rational design and mutagenesis, the CrpTE enzyme was engineered to achieve multi-functionality. The modified enzyme can catalyze macrocyclization reactions for multiple different substrate types and produce various cryptophycin analogs with different biological activities. This universalization of the enzyme's function allows a single enzymatic system to serve multiple synthetic purposes, expanding the range of producible analogs while maintaining high efficiency.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The approach allows for the generation of potent cryptophycin analogs with improved in vivo efficacy and reduced toxicity, facilitating their use in treating various cancers, including colorectal cancer, by leveraging the CrpTE's versatility in macrocyclization and enabling more efficient synthetic strategies.
Implementation Method 1
contacting a seco cryptophycin intermediate with a cryptophycin thioesterase under conditions suitable for macrocyclization
Implementation Method 2
utilizes a serine, histidine, aspartic acid catalytic triad to effect regio- and stereospecific cyclization
Data Source
AI summary
The disclosure provides cryptophycin intermediates, cryptophycin analogs, and cryptophycin chimeric molecules useful in treating cancer, as well as methods of producing these compounds and methods of treating cancer.